Skip to main content
Premium Trial:

Request an Annual Quote

Cathy Burzik, Mike Hunkapiller, Tony White, Denny Ware

Premium
Applied Biosystems President Cathy Burzik stepped down last week, a little more than two years after being tapped to run the business after Mike Hunkapiller retired.
 
She will now take over as CEO of Kinetic, a San Antonio-based company specializing in advanced wound care and therapeutic surfaces.
 
Applera President and CEO Tony White has become interim president. ABI said the changes are effective immediately.
 
In a statement, White said ABI “has a strong management team and organizational structure and is performing well, and we expect to continue with the strategies and the team that have revitalized the business.”
 
He said he and ABI’s directors will “carefully consider our alternatives for the management succession.”
 
Burzik took over the helm of ABI after Michael Hunkapiller retired in August 2004. She joined ABI in September 2003 from Johnson & Johnson, where she was president of the company’s Ortho-Clinical Diagnostics business. Before being named president of ABI, Burzik had been executive vice president and COO at ABI.
 
At Kinetic Burzik will replace Denny Ware, who had been planning to retire, Kinetic said in a statement.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.